SEC Form D · filed January 6, 2017
scPharmaceuticals Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (28)
Jack Khattar · Lexington, MADirectorKush Parmar · Lexington, MADirectorPieter Muntendam · Lexington, MAExec · DirectorTroy Ignelzi · Lexington, MAExecDorothy K. Coleman · Lexington, MADirectorMette K. Agger · Lexington, MADirectorAbraham Ceesay · Lexington, MAExecLeonard K. Schaeffer · Lexington, MADirectorJonathan Silverstein · San Francisco, CADirectorJohn G. Lowry · Durham, NCExec · DirectorAnthony M. Nee · Washington, Washington, D.C.ExecWilliam R. Ford · Washington, Washington, D.C.DirectorJulia L. Yan · VANCOUVER, British Columbia, CanadaDirectorTerry D. Mccallister · Washington, Washington, D.C.ExecConstantin Dietrich · MIAMI BEACH, FLDirectorArthur J. Benvenuto · Durham, NCDirectorLaura W. Mclachlan · VANCOUVER, British Columbia, CanadaDirectorAbhay Gandhi · Lexington, MADirectorDavid A. Cass · Medford, MAExec · DirectorKatrin M. Holzhaus · Medford, MADirectorLevi Baer · Chicago, ILDirectorAndreas Bergmann · MIAMI BEACH, FLDirectorDerek S. Bridges · Medford, MADirectorGeorge P. Clancy · Washington, Washington, D.C.DirectorVincent L. Ammann · Washington, Washington, D.C.ExecNancy C. Floyd · Washington, Washington, D.C.ExecAbhay Gandhi · Lexington, MADirectorJonathan Silverstein · New York, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗